ResMed | RMD - Capital Ordinário





Capital Ordinário Alterar Data
Ansell USD 142.94M 885.26M 2025-12
Artivion USD 47.84M 468K 2025-12
AtriCure USD 50.64M 7K 2026-06
Baxter International USD 516.45M 2.17M 2026-03
Cochlear AUD 65.4M 1.12B 2025-12
Cooper Companies USD 195.11M 14K 2026-03
CSL USD 482.13M 93.87M 2025-12
Dexcom USD 385.9M 1.1M 2026-03
Edwards Lifesciences USD 577M 3.7M 2026-03
Fisher Paykel Healthcare NZD 586.94M 313.22K 2026-06
Globus Medical USD 135.06M 449K 2025-12
Haemonetics USD 46.83M 82K 2025-12
Idexx Laboratories USD 79.24M 611K 2026-03
Inogen USD 23K 0 2023-12
Insulet USD 69.26M 1.08M 2026-03
Integra LifeSciences USD 77.82M 69K 2026-03
Intuitive Surgical USD 354.16M 1.01M 2026-06
Medtronic USD 1.28B 1.38M 2025-12
Philips EUR 952.02M 729K 2026-03
Ramsay Health Care AUD 229.93M 29.81K 2025-12
ResMed USD 190.83M 44.86M 2026-03
Sigma Healthcare AUD 11.5B 9.93B 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Steris USD 98.07M 72K 2026-03
Teleflex USD 44.26M 70K 2026-03
Thermo Fisher Scientific USD 371.62M 1000 2026-06